0000000000618730

AUTHOR

Neil D. Christensen

showing 3 related works from this author

Further Evidence that Papillomavirus Capsids Exist inTwo DistinctConformations

2003

ABSTRACT Cell surface heparan sulfate proteoglycans (HSPGs) serve as primary attachment receptors for human papillomaviruses (HPVs). To demonstrate that a biologically functional HPV-receptor interaction is restricted to a specific subset of HSPGs, we first explored the role of HSPG glucosaminoglycan side chain modifications. We demonstrate that HSPG O sulfation is essential for HPV binding and infection, whereas de-N-sulfated heparin interfered with VLP binding but not with HPV pseudoinfection. This points to differences in VLP-HSPG and pseudovirion-HSPG interactions. Interestingly, internalization kinetics of VLPs and pseudovirions, as measured by fluorescence-activated cell sorting analy…

Conformational changeProtein Conformationvirusesmedia_common.quotation_subjectImmunologyReplicationBiologyAntibodies ViralMicrobiologyEpitopeEpitopesMiceCapsidProtein structureNeutralization TestsVirologyChlorocebus aethiopsAnimalsHumansReceptorInternalizationPapillomaviridaemedia_commonCOS cellsVirionAntibodies MonoclonalCell sortingFlow CytometryMolecular biologyCell biologycarbohydrates (lipids)CapsidInsect ScienceCOS CellsReceptors VirusCapsid ProteinsHeparan Sulfate ProteoglycansJournal of Virology
researchProduct

Immunological analyses of human papillomavirus capsids

2001

Recombinant human papillomavirus (HPV) virus-like particles (VLPs) are promising vaccine candidates for controlling anogenital HPV disease. Questions remain, however, concerning the extent of capsid antigenic similarity between closely related virus genotypes. To investigate this issue, we produced VLPs and corresponding polyclonal immune sera from several anogenital HPV types, and examined these reagents in enzyme-linked immunosorbent assays (ELISAs) and in cross-neutralization studies. Despite varying degrees of L1 genetic sequence relatedness, VLPs of each type examined induced high-titer serum polyclonal antibody responses that were entirely genotype-specific. In an in vitro infectivity…

Protein DenaturationGenotypeProtein ConformationvirusesEnzyme-Linked Immunosorbent AssayVaccinia virusCross ReactionsBiologyAntibodies ViralRecombinant virusEpitopeVirusAbsorptionEpitopesCapsidVirus-like particleAntibody SpecificityNeutralization TestsAntigenic variationHumansSerotypingAntigens ViralPapillomaviridaeAntiserumVaccines SyntheticGeneral VeterinaryGeneral Immunology and MicrobiologyImmune SeraViral VaccinePublic Health Environmental and Occupational HealthAntibodies Monoclonalvirus diseasesViral VaccinesVirologyInfectious DiseasesCapsidMolecular MedicineVaccine
researchProduct

Heparin-based ELISA reduces background reactivity in virus-like particle-based papillomavirus serology.

2004

The interaction between human papillomavirus (HPV) particles and cell surface heparan sulfate requires intact conformation of the HPV particles. Type-specific HPV serology is currently based on virus-like particles (VLPs) with intact conformation. Presence of incorrectly folded VLPs in VLP preparations is recognized as an important cause of cross-reactivity in HPV serology. Heparin-coated microtitre plates were evaluated for capturing conformationally correct VLPs and improving the type specificity of HPV serology. Hybrid VLPs between HPV16 and HPV11, which had been found to have significant reactivity with children's sera and a batch of HPV18 VLPs that had failed the quality control becaus…

AdultMaleQuality ControlAdolescentmedicine.drug_classvirusesEnzyme-Linked Immunosorbent AssayBiologyCross ReactionsMonoclonal antibodyAntibodies Viralcomplex mixturesSensitivity and SpecificityEpitopeSerologyMicrobiology in the medical areachemistry.chemical_compoundAntigenVirus-like particleVirologymedicineHumansSerologic TestsChildAntigens ViralPapillomaviridaeAgedAged 80 and overHeparinPapillomavirus Infectionsvirus diseasesHeparan sulfateHeparinMiddle AgedVirologyMolecular biologychemistryChild Preschoolbiology.proteinFemaleAntibodymedicine.drugThe Journal of general virology
researchProduct